This inventor holds 1 USPTO granted patent. Top assignee: Dakocytomation Denmark A/s. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Johanna Suwinski: Innovator in Monoclonal Antibodies
Introduction
Johanna Suwinski is a prominent inventor based in Wiemersdorf, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies.
Latest Patents
Johanna holds a patent for "Monoclonal antibodies against human protein Mcm3, process for their production, and their use." This invention relates to monoclonal antibodies that specifically target the human Mcm3 protein. The patent outlines hybridoma cell lines that produce these antibodies, detailing procedures for their production and applications in pharmaceutical compositions. The antibodies developed can be utilized for the prevention and treatment of diseases associated with Mcm3 expression, showcasing their potential in medical diagnostics and therapeutics.
Career Highlights
Johanna Suwinski is associated with Dakocytomation Denmark A/S, where she has been instrumental in advancing research in her field. Her work has led to innovative solutions that enhance the understanding and treatment of diseases linked to the Mcm3 protein.
Collaborations
Johanna has collaborated with notable colleagues, including Johannes Gerdes and Thomas Scholzen, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Johanna Suwinski's work in monoclonal antibodies represents a significant advancement in biotechnology, with the potential to impact medical science profoundly. Her contributions continue to pave the way for future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile